This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Nov;8(11):e783-e784.

doi: 10.1016/S2352-3026(21)00312-4.

Redefining high hyperdiploid B-cell acute lymphoblastic leukaemia

Marina Lafage-Pochitaloff¹

Affiliations

Affiliation

¹ Hematological Cytogenetics Laboratory, Timone Children's Hospital, Aix-Marseille University, Marseille 13005, France. Electronic address: marina.lafage@ap-hm.fr.

PMID: 34715041
DOI: 10.1016/S2352-3026(21)00312-4

Comment

Redefining high hyperdiploid B-cell acute lymphoblastic leukaemia

Marina Lafage-Pochitaloff. Lancet Haematol. 2021 Nov.

. 2021 Nov;8(11):e783-e784.

doi: 10.1016/S2352-3026(21)00312-4.

Author

Marina Lafage-Pochitaloff¹

Affiliation

¹ Hematological Cytogenetics Laboratory, Timone Children's Hospital, Aix-Marseille University, Marseille 13005, France. Electronic address: marina.lafage@ap-hm.fr.

PMID: 34715041
DOI: 10.1016/S2352-3026(21)00312-4

No abstract available

PubMed Disclaimer

Conflict of interest statement

I declare no competing interests.

Comment on

Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
Enshaei A, Vora A, Harrison CJ, Moppett J, Moorman AV. Enshaei A, et al. Lancet Haematol. 2021 Nov;8(11):e828-e839. doi: 10.1016/S2352-3026(21)00304-5. Lancet Haematol. 2021. PMID: 34715050 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science